MedTrace Logo

S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia

NCT00899743 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2015-03-06

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood and bone marrow samples from patients with previously untreated primary acute myeloid leukemia.

Conditions

Interventions

GENETIC

polyacrylamide gel electrophoresis

polyacrylamide gel electrophoresis

GENETIC

western blotting

western blotting

OTHER

immunologic technique

immunologic technique

OTHER

laboratory biomarker analysis

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Steven J. Collins, MD · Fred Hutchinson Cancer Center

Eligibility

Min Age
56 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-06-30
Completion
2009-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00899743 on ClinicalTrials.gov